TITLE

Estimating the willingness to pay for a quality-adjusted life year in Thailand: does the context of health gain matter?

AUTHOR(S)
Thavorncharoensap, Montarat; Teerawattananon, Yot; Natanant, Sirin; Kulpeng, Wantanee; Yothasamut, Jomkwan; Werayingyong, Pitsaphun
PUB. DATE
January 2013
SOURCE
ClinicoEconomics & Outcomes Research;2013, Vol. 5, p29
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: This study aims to elicit the value of the willingness to pay (WTP) for a quality-adjusted life year (QALY) and to examine the factors associated with the WTP for a QALY (WTP/QALY) value under the Thai health care setting. Methods: A community-based survey was conducted among 1191 randomly selected respondents. Each respondent was interviewed face-to-face to elicit his/her health state preference in each of three pairs of health conditions: (1) unilateral and bilateral blindness, (2) paraplegia and quadriplegia, and (3) mild and moderate allergies. A visual analog scale (VAS) and time trade off (TTO) were used as the eliciting methods. Subsequently, the respondents were asked about their WTP for the treatment and prevention of each pair of health conditions by using a bidding-game technique. Results: With regards to treatment, the mean WTP for a QALY value (WTP/QALYtreatment) estimated by the TTO method ranged from 59,000 to 285,000 baht (16.49 baht = US$1 purchasing power parity [PPP]). In contrast, the mean WTP for a QALY value in terms of prevention (WTP/QALYprevention) was significantly lower, ranging from 26,000 to 137,000 baht. Gender, household income, and hypothetical scenarios were also significant factors associated with the WTP/QALY values. Conclusion: The WTP/QALY values elicited in this study were approximately 0.4 to 2 times Thailand's 2008 GDP per capita. These values were in line with previous studies conducted in several different settings. This study's findings clearly support the opinion that a single ceiling threshold should not be used for the resource allocation of all types of interventions.
ACCESSION #
85981107

 

Related Articles

  • The Value of a QALY: Individual Willingness to Pay for Health Gains Under Risk. Bobinac, Ana; Exel, Job; Rutten, Frans; Brouwer, Werner // PharmacoEconomics;Jan2014, Vol. 32 Issue 1, p75 

    Background: There is an increased interest in the monetary value of a quality-adjusted life-year (QALY). Past studies commonly derived willingness to pay (WTP) for certain future QALY gains. However, obtaining valid WTP per QALY estimates proved to be difficult. Objective: We conducted a...

  • I Am Not an Economist, But.. Gracy, John // Journal of Bone & Joint Surgery, American Volume;5/20/2015, Vol. 97 Issue 10, pe47-1 

    The author comments on the article "The Cost-Effectiveness of Surgical Treatment of Medial Unicompartmental Knee Osteoarthritis in Younger Patients. A Computer Model-Based Evaluation," by Joseph F. Konopka and colleagues. The author discusses the use of a computer model by the authors in...

  • Cost-Effectiveness of the Diabetes Care Protocol, a Multifaceted Computerized Decision Support Diabetes Management Intervention That Reduces Cardiovascular Risk. Cleveringa, Frits G. W.; Welsing, Paco M. J.; Van Den Donk, Maureen; Gorier, Kees J.; Niessen, Louis W.; Rutten, Guy E.H.M.; Redekop, William K. // Diabetes Care;Feb2010, Vol. 33 Issue 2, p258 

    OBJECTIVE -- The Diabetes Care Protocol (DCP), a multifaceted computerized decision support diabetes management intervention, reduces cardiovascular risk of type 2 diabetic patients. We performed a cost-effectiveness analysis of DCP from a Dutch health care perspective. RESEARCH DESIGN AND...

  • Dutch individuals place high monetary value on QALY.  // PharmacoEconomics & Outcomes News;Dec2013, Issue 693, p5 

    The article reports on the empirical study which estimates that the willingness to pay (WTP) per quality-adjusted life year (QALY) will range from 80 000 euros to 110 000 euros from the perspective of the individual in the Netherlands.

  • Putting willingness to pay in context.  // PharmacoEconomics & Outcomes News;1/26/2013, Issue 670, p9 

    The article discusses research which examined the willingness to pay (WTP) for quality-adjusted life year (QALY) in Thailand, referencing a study by M. Thavorncharoensap and colleagues, published in the January 2013 issue of "ClinicoEconomics and Outcomes Research."

  • Putting willingness to pay in context.  // PharmacoEconomics & Outcomes News;1/19/2013, Issue 670, p9 

    The article discusses research on the willingness to pay for a quality-adjusted life year in Thailand, referencing a study by M. Thavorncharoensap published in the January 2013 issue of "ClinicoEconomics and Outcomes Research."

  • Largely ignored: the impact of the threshold value for a QALY on the importance of a transferability factor. Vemer, Pepijn; Rutten-van Mölken, P. Maureen H. // European Journal of Health Economics;Oct2011, Vol. 12 Issue 5, p397 

    Recently, several checklists systematically assessed factors that affect the transferability of cost-effectiveness (CE) studies between jurisdictions. The role of the threshold value for a QALY has been given little consideration in these checklists, even though the importance of a factor as a...

  • Willingness to Pay for a QALY Based on Community Member and Patient Preferences for Temporary Health States Associated with Herpes Zoster. Lieu, Tracy A.; Ray, G. Thomas; Ortega-Sanchez, Ismael R.; Kleinman, Ken; Rusinak, Donna; Prosser, Lisa A. // PharmacoEconomics;2009, Vol. 27 Issue 12, p1005 

    Background and Objectives: A clear sense of what society is willing to pay for a QALY could enhance the usefulness of cost-effectiveness analysis as a field. Scant information exists on willingness to pay (WTP) for a QALY based on direct elicitation of preferences from community members or...

  • Exploring the willingness to pay for a qualityadjusted life-year in the state of Penang, Malaysia. Shafie, Asrul Akmal; Yen Wei Lim; Gin Nie Chua; Azmi, Mohammed; Hassali, Ahmad // ClinicoEconomics & Outcomes Research;2014, Vol. 6, p473 

    Introduction: The incremental cost-effectiveness ratio (ICER) is typically compared with a reference value to support the cost-effectiveness of a decision. One method for estimating this value is to estimate the willingness-to-pay (WTP) for a quality-adjusted life-year (QALY). This study was...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics